A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice

NCT05637112 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

551

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

OTHER: None (Observational study)

Sponsor

AstraZeneca

Collaborators

[object Object]